Literature DB >> 31243582

Anatomical hemispherectomy revisited-outcome, blood loss, hydrocephalus, and absence of chronic hemosiderosis.

Sandeep Sood1, Mohammed Ilyas2,3,4, Neena I Marupudi5, Eishi Asano2,3, Ajay Kumar2,3,6, Aimee Luat2,3, Sheena Saleem6, Harry T Chugani2,3,7.   

Abstract

PURPOSE: To evaluate microsurgical trans-sylvian trans-ventricular anatomical hemispherectomy with regard to seizure outcome, risk of hydrocephalus, blood loss, and risk of chronic hemosiderosis in patients with intractable seizures selected for surgery using current preoperative assessment techniques.
METHODS: Out of 86 patients who underwent hemispherectomy between February 2000 and April 2019, by a single surgeon, at a tertiary care referral center, 77 patients (ages 0.2-20 years; 40 females) who had an anatomical hemispherectomy were analyzed. Five of these were 'palliative' surgeries. One-stage anatomical hemispherectomy was performed in 55 children, two-stage anatomical hemispherectomy after extraoperative intracranial monitoring in 16, and six hemispherectomies were done following failed previous resection. Mean follow-up duration was 5.7 years (range 1-16.84 years). Forty-six patients had postoperative MRI scans.
RESULTS: Ninety percent of children with non-palliative hemispherectomy achieved ILAE Class-1 outcome. Twenty-seven patients were no longer taking anticonvulsant medications. Surgical failures (n = 4) included one patient with previous meningoencephalitis, one with anti-GAD antibody encephalitis, one with idiopathic neonatal thalamic hemorrhage, and one with extensive tuberous sclerosis. There were no failures among patients with malformations of cortical development. Estimated average blood loss during surgery was 387 ml. Ten (21%) children developed hydrocephalus and required a shunt following one-stage hemispherectomy, whereas 10 (50%) patients developed hydrocephalus among those who had extraoperative intracranial monitoring. Only 20% of the shunts malfunctioned in the first year. Early malfunctions were related to the valve and later to fracture disconnection of the shunt. One patent had a traumatic subdural hematoma. None of the patients developed clinical signs of chronic 'superficial cerebral hemosiderosis' nor was there evidence of radiologically persistent chronic hemosiderosis in patients who had postoperative MRI imaging.
CONCLUSION: Surgical results of anatomical hemispherectomy are excellent in carefully selected cases. Post-operative complications of hydrocephalus and intraoperative blood loss are comparable to those reported for hemispheric disconnective surgery (hemispherotomy). The rate of shunt malfunction was less than that reported for patients with hydrocephalus of other etiologies Absence of chronic 'superficial hemosiderosis', even on long-term follow-up, suggests that anatomical hemispherectomy should be revisited as a viable option in patients with intractable seizures and altered anatomy such as in malformations of cortical development, a group that has a reported high rate of seizure recurrence related to incomplete disconnection following hemispheric disconnective surgery.

Entities:  

Keywords:  Hemispherectomy; Hemispherotomy; Hemosiderosis; Hydrocephalus; PET scan; Seizures

Year:  2019        PMID: 31243582     DOI: 10.1007/s00381-019-04256-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  41 in total

1.  Disconnective hemispherectomy.

Authors:  C Di Rocco; A Iannelli
Journal:  Pediatr Neurosurg       Date:  2002-08       Impact factor: 1.162

2.  Peri-insular hemispherotomy in paediatric epilepsy.

Authors:  Jean-Guy Villemure; Roy Thomas Daniel
Journal:  Childs Nerv Syst       Date:  2006-06-29       Impact factor: 1.475

3.  ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery.

Authors:  H G Wieser; W T Blume; D Fish; E Goldensohn; A Hufnagel; D King; M R Sperling; H Lüders; T A Pedley
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

4.  Hemispherectomy for catastrophic epilepsy in infants.

Authors:  Jorge A González-Martínez; Ajay Gupta; Prakash Kotagal; Deepak Lachhwani; Elaine Wyllie; Hans O Lüders; William E Bingaman
Journal:  Epilepsia       Date:  2005-09       Impact factor: 5.864

5.  Hemimegalencephaly and intractable epilepsy: complications of hemispherectomy and their correlations with the surgical technique. A report on 15 cases.

Authors:  C Di Rocco; A Iannelli
Journal:  Pediatr Neurosurg       Date:  2000-10       Impact factor: 1.162

6.  Vertical parasagittal hemispherotomy: surgical procedures and clinical long-term outcomes in a population of 83 children.

Authors:  Olivier Delalande; Christine Bulteau; Georges Dellatolas; Martine Fohlen; Claude Jalin; Virginie Buret; Delphine Viguier; Georg Dorfmüller; Isabelle Jambaqué
Journal:  Neurosurgery       Date:  2007-02       Impact factor: 4.654

7.  Language recovery after left hemispherectomy in children with late-onset seizures.

Authors:  D Boatman; J Freeman; E Vining; M Pulsifer; D Miglioretti; R Minahan; B Carson; J Brandt; G McKhann
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

8.  Recovery of language after left hemispherectomy in a sixteen-year-old girl with late-onset seizures.

Authors:  Albert E Telfeian; Christina Berqvist; Craig Danielak; Scott L Simon; Ann-Christine Duhaime
Journal:  Pediatr Neurosurg       Date:  2002-07       Impact factor: 1.162

9.  Cerebral hemispherectomy in pediatric patients with epilepsy: comparison of three techniques by pathological substrate in 115 patients.

Authors:  Shon W Cook; Snow T Nguyen; Bin Hu; Sue Yudovin; W Donald Shields; Harry V Vinters; Barbara M Van de Wiele; Rick E Harrison; Gary W Mathern
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

10.  Anatomical hemispherectomy for intractable seizures: excellent seizure control, low morbidity and no superficial cerebral haemosiderosis.

Authors:  Donncha F O'Brien; Surajit Basu; Dawn H Williams; Paul L May
Journal:  Childs Nerv Syst       Date:  2006-02-10       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.